The aim of this study was to determine associations between aortic morphometry evaluated by cardiovascular magnetic resonance (CMR) and pregnancy outcomes in women with aortic coarctation (CoA).
Introduction
Coarctation of the aorta (CoA) accounts for 6-8% of adults with congenital heart disease (CHD). 1 In recent years, increasing numbers of women with CHD have been reaching reproductive age 2 and are seeking counselling regarding outcomes related to pregnancy. Pregnant women with CoA are at increased risk of cardiovascular complications; 3, 4 however, refined risk stratification based on aortic anatomy has not been described. While we have previously reported the association between maternal coarctation and gestational hypertension, 5 the mechanism underlying this association has not been established. Therefore, elucidation of the mechanistic role of aortic structure and/or function may enhance risk stratification during pregnancy. Cardiovascular magnetic resonance (CMR) in general, and contrast-enhanced three-dimensional magnetic resonance angiography (CE 3D-MRA) in particular, have emerged as the reference standard for the assessment of the aorta, 6 specifically in adults following CoA repair. 7 However, the literature contains a paucity of data regarding aortic narrowing in women with CoA undergoing pregnancy and is restricted to Doppler flow characteristics in a small subset of women within single-centre studies. 3, 4 We, therefore, sought to examine the association between aortic morphology as determined by CE 3D-MRA and risk of adverse events related to pregnancy in women with CoA. We hypothesized that an inverse relationship would exist between minimum aortic dimensions and risk of adverse events.
Methods Patients
Consecutive women of childbearing age with a diagnosis of CoA evaluated in Toronto (University Health Network/Mount Sinai Hospital) or Boston (Boston Children's Hospital/Brigham and Women's Hospital) from 1996 until 2010 were identified. Inclusion criteria consisted of a history of CoA (native or repaired) and a CMR evaluation with CE 3D-MRA performed within 2 years of delivery. Patients were excluded if the diagnosis of CoA was in association with complex CHD (i.e. single ventricle physiology) or if an aortic stent was present in the region of the isthmus due to anticipated metallic artefact, which would preclude accurate measurements. The research ethics boards of respective institutions approved this study. Baseline demographic data were recorded at the first clinic visit in pregnancy and included age, New York Heart Association (NYHA) functional class, baseline blood pressure (BP) (,14 weeks gestation), parity status, type of CoA repair, associated cardiac lesions, medications, and history of previous cardiovascular events of significance. The risk of developing adverse cardiac events in pregnancy (CARPREG score) was calculated for each patient entering pregnancy. 5 Completed pregnancy was defined as .20 weeks gestation. Follow-up clinical data were obtained from all available maternal and paediatric records.
Outcome events
Adverse pregnancy outcomes were classified as cardiovascular, obstetric, and foetal/neonatal outcomes. An adverse cardiovascular event was defined as any of the following: (i) hypertensive complication if systolic BP was ≥140 mmHg or diastolic BP was ≥90 mmHg and hypertension was either (a) a new diagnosis .20 weeks gestation (gestational hypertension); or (b) progressive with advancement of pregnancy despite escalating medical therapy (refractory hypertension); or (c) de novo and accompanied by new-onset of proteinuria .0.3 g/24 h (pre-eclampsia) 4, 8, 9 ; (ii) sustained arrhythmia requiring medical therapy or intervention; (iii) heart failure; (iv) stroke; (v) cardiac arrest; and/or (vi) cardiac death. 5 Obstetric events included post-partum haemorrhage (blood loss .500 mL after vaginal delivery or .1000 mL after caesarean section warranting transfusion or a drop in haemoglobin ≥20 g/L), premature rupture of membranes, and/or non-cardiac maternal death. 5 Foetal/neonatal events consisted of premature birth (,37 weeks gestation), small for gestational age birthweight (,10th percentile), respiratory distress syndrome, intraventricular haemorrhage, foetal demise (categorized as an abortion if ,20 weeks gestation and a stillbirth if ≥20 weeks) or neonatal death (within 28 days of birth). 5 The presence of CHD in offspring was not included as an adverse outcome of pregnancy.
CMR
Images were acquired on commercially available 1.5 T whole-body scanners with phased array surface coils. A CE 3D-MRA data set was acquired in sagittal/parasagittal orientation post-injection of 0.15 -0.2 mmol/kg of i.v. gadolinium chelate (gadobutrol in Toronto and gadopentetate dimeglumine in Boston, Bayer Healthcare, Berlin, Germany). Representative imaging parameters for the CE 3D-MRA sequence included a spatial resolution of 0.9 -1.1 mm × 1.0-1.1 mm × 1.2 -2.4 mm acquired in 19 -24 s for each of two sequential acquisitions performed under breathheld conditions, as previously described. 10 Bolus triggering based on contrast arrival in the ascending aorta was employed to determine optimal timing for image acquisition.
Image analysis
All CE 3D-MRA data sets were analysed using a dedicated workstation (Syngo MMWP, Siemens Healthcare, Erlangen, Germany). Multiplanar reformatted cross-sectional images of the aorta above the level of the valve were created by a single experienced reader (L.J.J.) at the following standardized locations: ascending aorta, distal transverse aortic arch, isthmus, descending thoracic aorta, and repair site, if applicable. 10 -12 The fullwidth at half-maximum technique of image contrast and brightness adjustment 13 was applied to ensure consistency and reproducibility of measurements ( Figure 1) . Measures of the aortic valve and root were Figure 1 Contrast-enhanced three-dimensional magnetic resonance angiography. Multiplanar reformatted images obtained using the 'double oblique' technique to ensure optimal plane of measurement (A-C). 'Full width at half maximum' method of windowing was used for the measurement of aortic dimensions and areas (D). 13 not entered into analysis, as cross-sectional cine sequences were not uniformly available. At each level of the aorta, both minimal diameter (caliper measurements) and cross-sectional area (planimetry measurements) were obtained. The minimum aortic dimension, typically at the isthmus or distal transverse arch, was visually identified and subsequent measurements were made.
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Statistical analysis
Statistical analysis was performed using the SPSS software version 20 (IBM SPSS Statistics 20, 2011 ). Continuous variables were described using mean and standard deviation and categorical variables using frequency and percentage. Demographic and clinical variables that are quantitative in nature and CMR variables (aortic dimensions) were compared between patients who experienced adverse events and those who did not using the Mann-Whitney U test. Fisher's exact test was used to assess the association between qualitative demographic and clinical variables and the occurrence of adverse events. Bonferroni correction was applied to adjust for multiple comparisons and the P-value was adjusted accordingly. Univariate logistic regression analysis was applied to examine the impact of each aortic dimension individually on the odds of having an adverse cardiovascular event. The resulting odds ratios and 95% confidence intervals (CI) are reported. Receiver operator curves were analysed to determine the optimal aortic dimension for discrimination of occurrence of an adverse event. The level of significance was set at P-value ,0.05 (two-sided).
Results
Clinical characteristics
A total of 88 women with a diagnosis of CoA followed through pregnancy were identified (68 from Toronto, 20 from Boston); however, 60 were excluded due to the absence of contemporary CMR imaging, leaving 28 women for analysis (22 from Toronto, 6 from Boston), with 30 completed pregnancies. All were in NYHA class I. Clinical data are detailed in Table 1 . On antenatal transthoracic echocardiography, all women had normal left ventricular systolic function (EF .55%); gradients across the isthmus/descending thoracic aorta [median 29 mmHg, range 10-54 (not corrected for proximal velocity)] were available in a subset of women (n ¼ 18); the presence of antegrade diastolic spillover in the abdominal aorta was not consistently reported and therefore could not be analysed. None of the women had documented coronary artery disease.
Cardiovascular outcomes related to pregnancy
A total of nine adverse cardiovascular outcomes were documented in the study population; these are detailed in Figure 2 . One woman with stroke and hypertension in pregnancy was diagnosed with a native CoA, and is the only one who required cardiac intervention (percutaneous stenting of the aorta 5 months post-partum). The second stroke event occurred in a normotensive woman and was related to an arteriovenous malformation. Both of the women who experienced sustained tachyarrhythmias had documented supraventricular tachycardias (atrial ectopic tachycardia in one and Wolff Parkinson White in the other) treated with anti-arrhythmic medications during pregnancy; the latter had a successful ablation following pregnancy. The median systolic BP of those with hypertensive events was 150 mmHg (range 140-200 mmHg) and aetiologies were gestational hypertension (n ¼ 3), refractory hypertension (n ¼ 1), and preeclampsia (n ¼ 1). In the five women with upper extremity systemic arterial hypertension, there was no clinical evidence of CoA based on documented corresponding leg pressures in four women (in one woman leg pressure measurements were not available): in three women systolic leg pressure measurements were not lower than right arm systolic measurements; in one woman the arm-leg BP differential was 30 mmHg, but this was not felt to represent recoarctation based on additional clinical features and available imaging data. Demographic and clinical features of those with and without cardiovascular and hypertensive events are summarized in The following factors were examined, but were not found to be statistically associated with cardiovascular events in general or hypertensive events in particular: age at first cardiac intervention, use of anti-hypertensive therapy during pregnancy, or the presence of significant left heart obstructive disease. 5 While the presence of native CoA vs. CoA repair trended towards but did not reach statistical significance for the occurrence of a cardiovascular event (P ¼ 0.068), there was no relationship between native CoA vs. CoA repair and hypertensive complications (P ¼ 0.183).
Obstetric and foetal/neonatal outcomes
Adverse obstetric outcomes were relatively uncommon ( Figure 2) . Previous spontaneous miscarriage/termination of pregnancy was documented in five women. Caesarean delivery occurred in 12 pregnancies exclusively for obstetric (rather than cardiac) indications. For the overall cohort, the mean gestational age at delivery was 38 + 2 weeks and birthweight was 3147 + 554 g (61 percentile). Women who experienced a cardiovascular event in pregnancy tended to have infants born earlier when compared with those who did not experience adverse cardiovascular events (35 + 7 weeks gestation vs. 39 + 2 weeks gestation, P ¼ 0.034). However, birthweight (absolute and percentile) was not statistically significant different between the groups (2640 + 1230 vs. 3286 + 588 g, P ¼ 0.332; 57 vs. 62 percentile, P ¼ 0.577). Similarly, women with hypertension in pregnancy tended to have more premature infants when compared with than those who did not have hypertensive complications (34 + 8 vs. 39 + 2 weeks, P ¼ 0.031), although birth weight (absolute and percentile) was similar between the groups (2540 + 1497 vs. 3249 + 602 g, P ¼ 0.5; 54 vs. 62 percentile, P ¼ 0.658). A total of 5 major foetal/neonatal events were recorded (Figure 2) . Two infants had minor CHD (one ventricular septal defect and one patent ductus arteriosus) but did not require further intervention.
CMR dimensions
All available CE 3D-MRA data sets were deemed technically adequate for analysis. There were neither aneurysms of the ascending aorta nor were there identifiable aneurysms at the CoA repair site. There were no cases of re-coarctation after initial repair; the ratio between the minimum aorta diameter and the aorta at the diaphragm was .0.5 in all patients (mean 0.7 + 0.10). 15 The difference in minimum aortic diameter between women with native compared with repaired CoA was not statistically significant (14.0 + 2 vs. 13.2 + 2 mm, P ¼ 0.368). Minimum aortic dimensions were most commonly observed at the isthmus/proximal descending thoracic aorta (n ¼ 21/28, 75%); minimum dimensions were present within the transverse arch in the remainder (n ¼ 7/28, 25%).
Relationship between CMR dimensions and pregnancy outcomes
Minimum aortic measurements were significantly smaller in women with, when compared to women without, adverse cardiovascular events ( Table 3) . By univariate logistic regression analysis, minimum aortic diameter (absolute and indexed for body surface area) was
Figure 2 Pregnancy outcomes in women with coarctation of the aorta (A). Relationships between minimum aortic dimensions and outcomes in pregnancy (B)
. SGA, small for gestational age; RDS, respiratory distress syndrome; PPH, post-partum hemorrhage; PRM, premature rupture of membranes.
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related to the odds of developing a cardiovascular event during pregnancy, whereas the minimum aortic area carried borderline statistical significance for the same. For each decrease in absolute aortic diameter of 1 mm, or indexed aortic diameter of 1 mm/m 2 , there was a three-fold increase in odds of occurrence of a cardiovascular event during pregnancy ( Table 4) .
A minimum aortic diameter ≤12 mm was identified as an important anatomic determinant of adverse cardiovascular outcomes. Based on receiver operator curve analysis, the 12 mm threshold was found to be the optimal discrimination point for development of a cardiovascular event with a sensitivity of 78%, specificity of 91%, positive predictive value (PPV) of 78%, negative predictive value (NPV) of 91% and area under the curve (AUC) 0. 855 In women with hypertensive events, receiver operatorcurve analysis similarly identified a threshold diameter of ≤12 mm as being both highly sensitive and specific for development of a hypertensive event with sensitivity 100%, specificity 92%, PPV 71%, NPV 100%, and AUC 0.976 (SE 0.025, 95% CI: 0.93-1). With the exception of one, all women with a minimum aortic diameter ≤12 mm (≤7 mm/m 2 ) experienced an adverse hypertensive event related to pregnancy (n ¼ 5/6, 83%). Logistic regression analysis was not achievable given the modest number of women with hypertensive events in this study.
Although development of cardiovascular and hypertensive events appeared to be related to aortic anatomy, neither obstetric nor foetal/neonatal events were statistically associated with aortic dimensions. Finally, there was no statistical association between aortic dimensions and birthweight.
Discussion
This is the first study to examine the relationship between aortic dimensions and pregnancy outcomes in women with CoA. We found that women with smaller aortic dimensions were more likely to experience hypertensive complications related to pregnancy. Conversely, those with larger aortic dimensions were free from adverse cardiovascular, obstetric and foetal/neonatal events. Our observations suggest that CMR-derived measurements of the aorta can aid in stratifying risk for women with CoA who are contemplating pregnancy.
Aortic coarctation is known to impart increased risk of cardiovascular complications in pregnancy; 3,4,9 however, existing literature has not addressed which women are more likely to have adverse pregnancy outcomes and what the underlying mechanism might be. Although previous studies in this population have inferred disease severity from Doppler-echocardiographic interrogation of the aortic arch/isthmus, current consensus guidelines for the management of the adult with CHD specifically state that 'Doppler gradients are not useful' for disease quantification in those with native or postoperative CoA. 15 While other echocardiographic parameters have been reported to be useful in determining significance of coarctation, they have either not been adapted widely or have not been adequately validated. 16 Consequently, meaningful conclusions about the impact of aortic narrowing on pregnancy outcome have been difficult to elucidate thus far.
In the non-pregnant CoA population, aortic narrowing, as determined by CMR, has been associated with hypertension.
14 CMR is widely recognized as the reference standard for the assessment of the diseased aorta 15 and it is therefore not surprising that current guidelines for the management of maternal cardiac disease state that imaging of the 'entire aorta' be performed with MRI or CT before pregnancy in women with 'known aortic disease' (class 1C). 8 However, the incremental benefit of CMR for management of the pregnant woman has not been studied in women with any form of structural heart disease. Our study, which provides crosssectional imaging data regarding aortic morphometry, is therefore unique in this regard and of potential clinical value.
Cardiovascular outcomes of pregnancy
We demonstrate that the development of adverse cardiovascular events in pregnancy is related to smaller aortic dimensions, either at the distal transverse arch or isthmus/proximal descending thoracic aorta. Specifically, a minimum aortic diameter of 12 mm is identified as the optimal threshold for predicting an adverse cardiovascular outcome in pregnancy, with moderate sensitivity and very good specificity. This threshold diameter provides even more robust discrimination regarding development of a hypertensive event with very good sensitivity and specificity. With only one exception, all women with a minimum aortic diameter ≤12 mm (≤7 mm/m 2 ) experienced a hypertensive event in pregnancy. On the other hand, women with a minimum aortic diameter which exceeds 15 mm do not seem to be at risk for development of any adverse outcome in pregnancy.
Previous series have reported hypertensive complications rates between 22 and 30% for the pregnant woman with CoA. 3, 4, 9 The lower prevalence of hypertensive complications in our study (17%) may be ascribed to several factors. We considered hypertension to be a significant event in pregnancy if it was a new diagnosis in pregnancy (i.e. gestational or pre-eclampsia) or if worsening hypertension was documented with progression of pregnancy despite escalation of medical therapy (i.e. refractory hypertension). This is in contrast to other studies where sustained hypertension (pre-dating pregnancy or present from the beginning of pregnancy) are included as adverse events, irrespective of the impact of pregnancy on disease progression. 3, 4, 9 Unlike some studies where BP values were selfreported, 3 we documented serial BP measurements throughout pregnancy. Finally, an additional factor, unique to our cohort, is the relatively common use of beta-adrenergic blocking drugs in our CoA population. As women with CoA have ongoing risk of aortopathy 8 and dissection, 3 particularly if associated with a bicuspid aortic valve, it has become practice in some institutions to consider empiric beta-blockade early in pregnancy, irrespective of normotensive BP measurements. The frequent use of beta-blockade in our population may have reduced the prevalence of hypertensive complications in the women studied.
Non cardiovascular outcomes of pregnancy
Obstetric complications were not prominent in our cohort, in keeping with published reports. 17 Although previous work has demonstrated an association between maternal cardiac disease in general, and significant maternal left heart obstructive disease in particular, to low birthweight 5,18 small for gestational age infants were not a feature of our cohort. Despite the occurrence of adverse cardiac events in almost one-third of our population and the common use of beta-adrenergic blocking drugs (the use of which has been implicated in small for gestational age infants, particularly in hypertensive mothers), the mean birthweight in our cohort was well within the normal range and not significantly lower in women who had hypertensive or cardiovascular complications. Our finding of five major foetal events in 30 pregnancies (17%) is similar to the frequency reported by other studies of pregnant women with CoA.
incorporated in the routine follow-up of adults with repaired CoA outside of pregnancy 6, 7 ; our study expands the utility of CMR, showing that there is added clinical value in women of childbearing age.
First, we demonstrate that minimum aortic measurements may be useful for risk stratification of women in pregnancy. Based on our observations, hypertensive events do not occur if the minimum aortic diameter exceeds 12 mm or 7 mm/m 2 and no adverse events occur when the minimum aortic diameter exceeds 15 mm. Given these data, aortic dimensions may help identify women at low risk of adverse events in pregnancy and those who would benefit from intervention prior to and/or heightened surveillance during pregnancy. Secondly, although not specifically observed in this study, additional benefits of CMR prior to pregnancy may include the identification of aneurysms (related to previous aortic repair or in those with a bicuspid aortic valve) that could pose risk of dissection/rupture if left unaddressed before pregnancy.
8,9
Limitations
The retrospective nature of this study and the relatively small sample size are noteworthy limitations. Inclusion of patients exclusively seen in tertiary care centres referred for CMR may impose a selection bias that would affect the generalizability of the results. Our study group likely represents a selected population and therefore our findings will need prospective validation in an independent group in which all women with CoA undergo CMR prior to pregnancy. In addition, information regarding pressure gradients across the arch/isthmus would have been desirable but was only available in a small subset of patients. Reassuringly, however, previous studies have established a strong relationship between aortic diameters and cross-sectional areas evaluated by CE 3D-MRA and direct haemodynamic measurements obtained during cardiac catheterization. 10 Finally, antenatal and postnatal CMR data would be very useful for fuller evaluation of the impact of the altered hormonal milieu and augmentation of cardiac output that occur in pregnancy on aortic anatomy.
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Such data were not available in the vast majority of patients in this study but will serve as a focus of future research efforts from our group. Current consensus opinion advises against the administration of gadolinium during pregnancy and it is therefore not surprising that 3D CE-MRA were not available during pregnancy. 24 
Conclusion
Hypertensive complications are the most commonly encountered adverse outcome related to pregnancy in women with a diagnosis of CoA. Minimum aortic diameter, as determined by CE 3D-MRA, appears to be related to development of adverse cardiovascular events in general, and hypertensive events in particular. All hypertensive events are seen in women with a minimum aortic diameter of ≤12 mm (≤7 mm/m 2 ) and this threshold diameter showed optimal discriminatory capacity for the development of adverse cardiovascular events in pregnancy. Detailed evaluation of aortic anatomy may assist in stratification of cardiovascular risk of women with CoA who are contemplating pregnancy.
